메뉴 건너뛰기




Volumn 36, Issue 7, 2010, Pages 814-822

Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: Formulation and storage stability

Author keywords

Gliclazide; Initial burst release; Matrix pellets; MCC powder coating; Storage ability

Indexed keywords

ETHYL CELLULOSE; GLICLAZIDE; MICROCRYSTALLINE CELLULOSE; POLYMER; SODIUM CARBOXYMETHYL STARCH; STARCH; UNCLASSIFIED DRUG;

EID: 77953216569     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903520967     Document Type: Article
Times cited : (11)

References (19)
  • 1
    • 0026764062 scopus 로고
    • Gliclazide: Metabolic and vascular effects - A perspective
    • Alberti KG, Johnson AB, Taylor R. (1992). Gliclazide: Metabolic and vascular effects - a perspective. Metabolism, 41(5 Suppl 1):40-5.
    • (1992) Metabolism , vol.41 , Issue.5 SUPPL. 1 , pp. 40-45
    • Alberti, K.G.1    Johnson, A.B.2    Taylor, R.3
  • 2
    • 70349303798 scopus 로고    scopus 로고
    • Drug release from MCC- and carrageenan-based pellets: Experiment and theory
    • Kranz H, Jurgens K, Pinier M, Siepmann J. (2009). Drug release from MCC- and carrageenan-based pellets: Experiment and theory. Eur J Pharm Biopharm, 73:302-9.
    • (2009) Eur J Pharm Biopharm , vol.73 , pp. 302-309
    • Kranz, H.1    Jurgens, K.2    Pinier, M.3    Siepmann, J.4
  • 3
    • 33947201622 scopus 로고    scopus 로고
    • Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms
    • Goole J, Vanderbist F, Amighi K. (2007). Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm, 334:35-41.
    • (2007) Int J Pharm , vol.334 , pp. 35-41
    • Goole, J.1    Vanderbist, F.2    Amighi, K.3
  • 4
    • 0035927204 scopus 로고    scopus 로고
    • An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen
    • Vergote GJ, Vervaet C, Van Driessche I. (2001). An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm, 219:81-7.
    • (2001) Int J Pharm , vol.219 , pp. 81-87
    • Vergote, G.J.1    Vervaet, C.2    Van Driessche, I.3
  • 5
    • 33745211208 scopus 로고    scopus 로고
    • Controlled drug release from gelucire-based matrix pellets: Experiment and theory
    • Siepmann F, Muschert S, Flament MP. (2006). Controlled drug release from Gelucire-based matrix pellets: Experiment and theory. Int J Pharm, 317:136-43.
    • (2006) Int J Pharm , vol.317 , pp. 136-143
    • Siepmann, F.1    Muschert, S.2    Flament, M.P.3
  • 6
    • 0027300501 scopus 로고
    • Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/spheronisation
    • Tapia C, Buckton G, Newton JM. (1993). Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/spheronisation. Int J Pharm, 92:211-8.
    • (1993) Int J Pharm , vol.92 , pp. 211-218
    • Tapia, C.1    Buckton, G.2    Newton, J.M.3
  • 7
    • 0242289048 scopus 로고    scopus 로고
    • Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique
    • DOI 10.1016/j.ijpharm.2003.07.012
    • Pearnchob N, Bodmeier R. (2003). Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique. Int J Pharm, 268:1-11. (Pubitemid 37487817)
    • (2003) International Journal of Pharmaceutics , vol.268 , Issue.1-2 , pp. 1-11
    • Pearnchob, N.1    Bodmeier, R.2
  • 8
    • 2642561045 scopus 로고    scopus 로고
    • Application of hot-melt coating for controlled release of propranolol hydrochloride pellets
    • Sinchaipanid N, Junyaprasert V, Mitrevej A. (2004). Application of hot-melt coating for controlled release of propranolol hydrochloride pellets. Powder Technol, 141:203-9.
    • (2004) Powder Technol , vol.141 , pp. 203-209
    • Sinchaipanid, N.1    Junyaprasert, V.2    Mitrevej, A.3
  • 9
    • 0344893332 scopus 로고
    • Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
    • Higuchi T. (1963). Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52:1145-9.
    • (1963) J Pharm Sci , vol.52 , pp. 1145-1149
    • Higuchi, T.1
  • 11
    • 2342652446 scopus 로고    scopus 로고
    • Mathematical comparison of dissolution profiles
    • Jeffrey WM, Henry HF. (1996). Mathematical comparison of dissolution profiles. J Pharm Tech, 20(6):64-74.
    • (1996) J Pharm Tech , vol.20 , Issue.6 , pp. 64-74
    • Jeffrey, W.M.1    Henry, H.F.2
  • 12
    • 0022384893 scopus 로고
    • Spheronization II: Drug release from drug-diluent mixtures
    • Connor REO, Schwartz JB. (1985). Spheronization II: Drug release from drug-diluent mixtures. Drug Dev Ind Pharm, 11:1837-57.
    • (1985) Drug Dev Ind Pharm , vol.11 , pp. 1837-1857
    • Connor, R.E.O.1    Schwartz, J.B.2
  • 13
    • 33747880054 scopus 로고    scopus 로고
    • Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets
    • Hu L-D, Liu Y, Tang X. (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur J Pharm Biopharm, 64:185-92.
    • (2006) Eur J Pharm Biopharm , vol.64 , pp. 185-192
    • Hu, L.-D.1    Liu, Y.2    Tang, X.3
  • 14
    • 33847118948 scopus 로고    scopus 로고
    • Matrices containing NaCMC and HPMC 1. Dissolution performance characterization
    • Conti S, Maggi L, Segale L. (2007). Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int J Pharm, 333:136-42.
    • (2007) Int J Pharm , vol.333 , pp. 136-142
    • Conti, S.1    Maggi, L.2    Segale, L.3
  • 15
    • 70350650228 scopus 로고    scopus 로고
    • Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets
    • Zhang X, Tang X, Yang R. (2008). Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Dev Ind Pharm, 1:1-8.
    • (2008) Drug Dev Ind Pharm , vol.1 , pp. 1-8
    • Zhang, X.1    Tang, X.2    Yang, R.3
  • 16
    • 0021904208 scopus 로고
    • Analysis of fickian and non-fickian drug release from polymers
    • Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110-1.
    • (1985) Pharm Acta Helv , vol.60 , pp. 110-111
    • Peppas, N.A.1
  • 17
    • 42749090555 scopus 로고    scopus 로고
    • Novel use of eudragit®NE30D/eudragit®L30D-55 blends a functional coating materials in time-delayed drug release applications
    • El-Malah Y, Nazzal S. (2008). Novel use of Eudragit®NE30D/ Eudragit®L30D-55 blends a functional coating materials in time-delayed drug release applications. Int J Pharm, 357:219-27.
    • (2008) Int J Pharm , vol.357 , pp. 219-227
    • El-Malah, Y.1    Nazzal, S.2
  • 18
    • 34249042906 scopus 로고    scopus 로고
    • How to adjust desired drug release patterns from ethylcellulose-coated dosage forms
    • Siepmann F, Hoffmann A, Leclercq B. (2007). How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Control Release, 119:182-9.
    • (2007) J Control Release , vol.119 , pp. 182-189
    • Siepmann, F.1    Hoffmann, A.2    Leclercq, B.3
  • 19
    • 38749109224 scopus 로고    scopus 로고
    • How to improve the storage stability of aqueous polymeric film coatings
    • Siepmann F, Muschert S, Leclercq B. (2007). How to improve the storage stability of aqueous polymeric film coatings. J Control Release, 126:26-33.
    • (2007) J Control Release , vol.126 , pp. 26-33
    • Siepmann, F.1    Muschert, S.2    Leclercq, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.